Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DRF94Z
|
|||
| Drug Name |
AIV001
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Basal cell carcinoma [ICD-11: 2C32; ICD-10: C44] | Phase 1/2 | [1] | |
| Company |
AiViva BioPharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Vascular endothelial growth factor receptor (VEGFR) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04470726) Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of AiViva BioPharma. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.